Image

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Checking healthy stool for C. difficile toxins after antibiotic treatment.

Recruiting
18-75 years
All
Phase N/A
This study explores recurrence of **C. Difficile infections (CDI)**, a bacterial infection causing diarrhea and more serious intestinal conditions, after standard antibiotic treatments. **C. Difficile** bacteria can produce toxins like **Toxin A and B**, which are harmful substances causing symptoms. Researchers aim to see how often the infection returns within **8 weeks** after treatment, and whether these toxin levels can predict recurrence. Participants will need to: - Be adults aged **18-75** with a history of CDI recurrence. - Have completed a recent antibiotic treatment and be symptom-free when starting the study. - Provide stool samples and attend **4 clinic visits** over about **9 weeks**; some visits can be by phone. **Key Points:** - Participants must have a documented CDI recurrence and completed treatment. - The study involves providing stool samples and attending multiple visits. - Individuals with certain health conditions or recently involved in other studies are excluded. This study helps in understanding how to better predict and prevent CDI recurrences, potentially improving treatment strategies. Participants will be screened for eligibility before enrolling.
Study details
    Clostridioides Difficile Infection Recurrence

NCT07250724

Bactolife A/S

7 March 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.